Dental products company Envista Holdings (NYSE:NVST) announced better-than-expected revenue in Q1 CY2026, with sales up 14.4% year on year to $705.5 million. Its non-GAAP profit of $0.36 per share was ...
24/7 Wall St. on MSN
Americans are cutting spending on everything except healthcare. These 2 medical device stocks under $30 are built to win
Quick Read Envista (NVST) posted Q1 FY26 revenue of $705.5M growing 14.4% year-over-year with adjusted EPS of $0.36 topping ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...
Zacks Investment Research on MSN
Envista (NVST) international revenue performance explored
Have you assessed how the international operations of Envista (NVST) performed in the quarter ended March 2026? For this maker of dental products, possessing an expansive global footprint, parsing the ...
Envista's earnings beat consensus, thanks to a defensive dental market and the company's own cost reduction efforts. Find out ...
Dental products company Envista Holdings (NYSE:NVST) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 14.4 ...
Ariel Investments, an investment management company, released its “Ariel Fund" Q1 2026 Investor Letter. A copy of the letter ...
In recent trading, shares of Envista Holdings Corp (Symbol: NVST) have crossed above the average analyst 12-month target price of $18.04, changing hands for $18.13/share. When a stock reaches the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results